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Abstract
Experimental conditions or the presence of interacting components can lead to variations in the structural models of
macromolecules. However, the role of these factors in conformational selection is often omitted by in silico methods to
extract dynamic information from protein structural models. Structures of small peptides, considered building blocks for
larger macromolecular structural models, can substantially differ in the context of a larger protein. This limitation is more
evident in the case of modeling large multi-subunit macromolecular complexes using structures of the individual protein
components. Here we report an analysis of variations in structural models of proteins with high sequence similarity. These
models were analyzed for sequence features of the protein, the role of scaffolding segments including interacting proteins
or affinity tags and the chemical components in the experimental conditions. Conformational features in these structural
models could be rationalized by conformational selection events, perhaps induced by experimental conditions. This analysis
was performed on a non-redundant dataset of protein structures from different SCOP classes. The sequence-conformation
correlations that we note here suggest additional features that could be incorporated by in silico methods to extract
dynamic information from protein structural models.
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Introduction
The substantial improvement in the methodology of protein
structure determination is reflected by an exponential increase in
the number of structures deposited in the Protein Data Bank
(PDB) [1]. Functional annotation and mechanistic interpretations
of several of these structural models, however, remains a
significant hurdle. Information on protein dynamics and confor-
mational variations is an important input for mechanistic
interpretation. While this information is experimentally captured
by Nuclear Magnetic Resonance (NMR) spectroscopy methods,
structural models determined by X-Ray crystallography have to be
further subjected to intensive computational methods for dynamic
information. In silico strategies to obtain dynamic information are
both time-consuming and have an inherent limitation as they do
not explicitly incorporate experimental errors and artifacts
induced by experimental conditions. While experimental errors
can, in principle, be incorporated in computational simulations,
these require access to unprocessed experimental data that is not
currently freely available to analyze. Experimental conditions, on
the other hand, are available either with the structural coordinates
or in manuscripts that describe macromolecular structures in more
detail. An examination of protein structural models along with
experimental conditions could potentially aid in de-convoluting
conformational selection induced during the structure determina-
tion process.
It is increasingly apparent that a single structural model of a
protein is likely to be incomplete in its information content-
given that it provides a single representation of several flexible
segments and alternative conformations. It is thus imperative to
de-convolute the dynamics and alternate conformations from a
structural model to obtain a more functionally relevant model of
a biological molecule. In silico strategies, such as Molecular
Dynamics (MD) simulations, from-CONstraints-to-COORDi-
nates (CONCOORD) analysis or more often, normal modes
analysis are employed to extrapolate dynamic motions of a
protein from a single experimentally determined structural
model. These techniques, however, do not explicitly incorporate
features such as experimental conditions or the propensity of a
protein stretch to adopt conformations other than that modeled
by the experimenter. The large number of structures present in
the protein data bank suggests that a systematic analysis of these
parameters could form a potentially useful source of information
to interpret protein structures solved at high resolution. A
reliable de-convolution of dynamic information that accounts for
experimental artifacts could also aid in structure-based func-
tional annotation. Indeed, a protocol that incorporates dynamic
information from small protein domains to predict structural
variations in large macromolecular complexes could provide
valuable mechanistic information. An essential requirement
towards these goals is an estimate of the influence of
experimental parameters in the selection of alternate conforma-
tions that were modeled in X-Ray crystal structures or were
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retained in an NMR derived structural ensemble. In this study,
we examine differences between structural models that share
high sequence similarity to obtain an estimate of context-
dependent remodeling or conformational selection. The dataset
for this analysis comprised structural models derived by X-Ray
and NMR methods encompassing five Structural Classification
of Proteins (SCOP) classes. Multi-protein complexes and
structures of peptides determined independently and as a part
of large proteins were included in this analysis. Structural
variations within this data-set were examined for intrinsic
(sequence-based) features as well as external (experimental)
parameters. This analysis highlights structural differences and
provides a dataset to test in silico methods to extract dynamic
properties of proteins while explicitly incorporating the influence
of experimental parameters on structural models.
Figure 1. Summary of the dataset of molecular models examined for structural variations and conformational selection by
experimental methods. (A) The initial dataset of proteins was compiled for a representative sampling of folds and families. After selecting protein-
structural pairs based on experimental and sequence criteria, the dataset for analysis included 31 different protein pairs across five different structural
classes. (B) Bar diagrams represent the protein-protein, protein-nucleic acid complexes and peptides used in this study. Dark blue bars in all the
classes represent the initial selection from a set of 183 protein-protein complexes, 82 protein-nucleic acid complexes and 110 peptide structures. The
final composition of this dataset (shown here in gray and light blue bars) is based on the sequence and structural criteria described in the methods
section of this manuscript.
doi:10.1371/journal.pone.0039993.g001
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Results
A mechanistic interpretation of the function and regulation of a
protein crucially depends on information on the dynamic motions
and alternate conformations that could be adopted by its structure.
An estimate of the extent of conformational variation in structural
models of proteins that share high sequence similarity can provide
vital inputs to incorporate alternate conformations for a given
molecular model. This data, however, requires additional infor-
mation to distinguish between inherent flexibility vis-a`-vis struc-
tural variations that can be explained by experimental conditions.
Experimental context in this case includes factors that influence
conformation by virtue of interactions between polypeptide
fragments, concentration dependent and osmolyte-induced effects
as well as ligand interactions. A representative dataset of protein
structural models was collated to examine the effect of exper-
imental conditions on conformational selection.
Dataset of Proteins for Comparative Analysis
The dataset for this analysis includes high resolution crystal
structures, NMR structural ensembles, protein structures that were
determined in both the free-state (apo) as well as complexes with
ligands or as a component of a large macromolecular complex. A
pictorial description of this dataset is shown in Figure 1. This
dataset incorporates all SCOP classes of proteins except
membrane proteins. As there were no suitable NMR entries for
multi-domain proteins and very few structures in the category of
membrane and cell surface proteins, these classes were not
included in this study. Protein structures were retrieved from the
PDB based on folds, super-families and families which yielded a
total of 1086 folds, 1777 super-families and 3464 families [2].
Further pruning based on sequence and structural criteria resulted
in 233 structures spread across 5 classes of proteins viz., a, b, a+b,
a/b and small proteins. A sub-set of 31 protein pairs that shared
high sequence similarity but showed prominent differences in
conformation were chosen for detailed analysis (Table 1, Table
S1). Information on disordered proteins was obtained from the
DISPROT database [3]. From this dataset of 183 protein-protein
and 82 protein-nucleic acid complexes, 90 protein complexes and
35 protein-nucleic acid complexes were selected for further
analysis. We found 52 protein-protein complexes and 20
protein-nucleic acid complexes that showed substantial variation
in their structures between the free form, as a part of larger
complexes or in some cases between different multi-protein
complexes. Although peptides are not a true SCOP class, these
were also included (110 structures) to examine the influence of
context on structure. 45 amongst these peptide structures had an
equivalent stretch (sequence identity .80%) in a larger protein
(Figure 1B). The final dataset of protein complexes and peptide
structures that show conformational variation are listed in Tables 2
and 3.
Variations between Solution and Crystal Structures
A comparison between crystal and NMR structures provides
experimental evidence for conformational variation and sampling.
In the all a family, most differences, although not all, between the
solution and crystal structures could be rationalized to ligand
binding. For example, the S100 protein has been structurally
characterized in the Ca2+- free form (PDB: 1K9P), the Ca2+-
bound form (PDB: 1K96) [4] and in solution (PDB: 1A03) [5]. In
the X-ray structure, the stretch proximal to the ligand binding site
adopts a helical conformation in the crystal structure whereas it is
unstructured in the NMR structure despite the presence of a
bound Ca2+ cofactor. Another example of conformational change
induced by ligand binding are the crystal (PDB: 1GU2) and
solution structures (PDB: 1E8E) of the oxidized form of
Cytochrome C that reveal structural differences closer to the
heme binding pocket [6], [7]. These include a stretch I28–N36
(ITDGKIFFN) that adopts a helical conformation in the crystal
structure while it is unstructured in solution. The segments A48–
T54 (ACASCHT) and G61–I70 (GKNIVTGKEI) adopt a-helical
and b-sheet conformation in the crystal structure as opposed to
hydrogen bonded turns in solution. These structural variations are
highlighted in Figure 2A.
Plastocyanins are a good example of structural differences in the
b-class of proteins. The X-ray (2GIM) [8] and solution structures
(1FA4) [9] of Anabaena variabilis plastocyanin differ in their
secondary structural content (Figure 2B). b-strands are less
structured in solution compared to crystal structures where they
form extended b strands. Also, residues S52–S60 (SADLAKSLS)
and E90–G96 (EPHRGAG) in the crystal structure from A.
variabilis plastocyanin and the corresponding region in the
Phormidium laminosum homologue (PDB: 2Q5B) are a-helical in
the crystal structure while they remain unstructured in solution.
Three pilin crystal structures (a + b family in SCOP) exemplify
variations in this structural class. The structural descriptions
include N. gonorrhoeae strain MS11 pilin [10], the truncated toxin-
coregulated pilin from V. cholerae [11] the P. aeruginosa strain K pilin
[12] and the DK122–4 pilin examined by NMR [13]. The
DK122–4 crystal structure (PDB: 1QVE) exhibits a characteristic
type IVa pilin fold, with the N-terminal a-helix (a1–C) packed
onto a four-stranded antiparallel b-sheet. Although the relative
positions of the core secondary structure elements are well-
conserved among the crystal structures, they differ considerably
between the crystal and NMR structure of DK122–4 pilin (PDB:
1HPW). Superposition of these structures shows that in the
solution structure of DK122–4, the N-terminal a-helix A31–G55
(AQLSEAMTLASGLKTKVSDIFSQDG) is shifted by one turn
and thus deflected away from the b-sheet [12]. The C-terminal
residues V78–A88 (VAKVTTGGTA) form a b-strand in the
crystal structure whereas they are unstructured in solution
(Figure 2C).
ADP-ribosylation factors (ARF-1) belong to the a/b family of
proteins. Structural comparison in this case was made using four
structural models viz., the GDP bound structure of human ARF-1
(1HUR), rat ARF-1 (1RRF) and human ARF-1 (1U81) [14]. A
comparison between the crystal and solution structures reveals
several changes. The region P76–N84 (PLWRHYFQN) is helical
in solution NMR (1U81) but unstructured in the crystal structure.
Other differences include regions M18–M22 (MRILM), V43–V53
(VTTIPTIGFNV) and T85–V92 (TQGLIFVV) which are b-
strands in the crystal structures of these ARFs but are unstructured
or adopt turns/bridges in solution. Similarly, R99–E113
(RVNEAREELMRMLAE) is a well defined a-helical stretch
present in the crystal structure while in solution this stretch is a mix
of a hydrogen bonded turn (R99–E102), a short helix (E102–L107)
followed by another hydrogen bonded turn (M108–E113;
Figure 2D). Another prominent example is that of Rubredoxin
where the major difference between the X-Ray (PDB: 1BRF) [15]
and NMR structure (PDB: 1RWD) is the absence of b-strands in
solution (Figure 2E).
Structural Variation Due to Conformational Restraints in a
Larger Macromolecular Complex
An experimental construct that allows a recombinant protein to
be purified in large amounts to homogeneity is a critical step
towards structure determination. Important variables in this step
include the length of the recombinant protein along with the
Conformational Variation in Macromolecular Models
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Table 1. Comparison between X-ray and NMR structures in different classes of proteins.
a-class of proteins
X-ray/NMR PDB
Identity
(%) Variant Region Structural manifestation in crystal and solution structure PSIPRED analysis
1K96/1A03 90 42:51 - LTIGSKLQDA a-helix in crystal structure; Unstructured in solution a-helix
1GU2/1E8E 100 28:36 - ITDGKIFFN a-helix in crystal structure; Unstructured in solution b-strand +Coil
48:54 - ACASCHT a-helix in crystal structure; Hydrogen bonded turn in solution b-strand +Coil
61:70- GKNIVTGKEI b-strand and turn in crystal structure; b- bridge in solution b-strand +Coil
1NZN/1PC2 78.1 5:13 - EAVLNELVSVED a-helix in crystal structure; Unstructured in solution a-helix
1I27/1NHA 86.6 478:483- QTKKTGL a-helix in crystal structure; Unstructured in solution a-helix
1OMR/1JSA 100 97:109- TNQKLEWAFSLY 310-helix and a-helix in crystal structure; Unstructured in solution a-helix
1HH5/1F22 100 17:29 - HKAHAEKLGCDAC a-helix and 310-helix in crystal structure; a-helix and coil in solution Coil
61:66 - KCGGCH a-helix in crystal structure; Unstructured in solution Coil + b-strand
1H0A/1INZ 88.9 3:15 - TSSLRRQMKNIVH a-helix in crystal structure; Unstructured in solution a-helix
5P2P/1SFV 91.9 18:22 - PLMDF a-helix in crystal structure; Unstructured in solution Coil
113:115- KEH 310-helix and b-bridge in crystal structure; b-bridge in solution ND
120:123- TKKY a-helix in crystal structure; Unstructured in solution ND
b-class of proteins
1OPA/1B4M 100 27:35 - FATRKIAVR a-helix in crystal structure; Unstructured in solution a -helix
5:14 - NGTWEMESNE b-strand in crystal structure; Small b-strand and unstructured
in solution
b-strand
72:75 - EHTK b-strand and turn in crystal structure; unstructured in solution ND
1XCA/1BLR 99.3 28:38 - LRKIAVAAASK a-helix in crystal structure; Unstructured in solution a -helix
127:137- DVVCTRVYVRE b-strand in crystal structure; Small b-strand and turn in solution b-strand
60:66 - TTEINFK b-strand in crystal structure, unstructured in solution b-strand
2GIM/1FA4 99.1 2:7 - ETYTVKL b-strand in crystal structure; Unstructured in solution b-strand
52:60 - SADLAKSLS a-helix in crystal structure; Unstructured in solution a-helix
83:89 - GEYTFYC b-strand in crystal structure; Unstructured in solution b-strand
90:96 - EPHRGAG a-helix in crystal structure; Unstructured in solution Coil
1SPD/1RK7 96.1 41:48 - GLHGFHVH b-strand in crystal structure; Unstructured in solution b-strand
85:89 - NVTA b-strand in crystal structure; Unstructured in solution ND
97:99 - VSI b-strand in crystal structure; b-strand in solution ND
116:120- TLVVH b-strand in crystal structure; Unstructured in solution ND
54:60 - TAGCTSA Turn in crystal structure; Unstructured in solution Coil
132:137- EESTKT a-helix in crystal structure; Hydrogen bonded in solution Coil
1J2A/1CLH 99.4 38:45 - SGFYNNTT Hydrogen bonded turn and b-sheet; Unstructured in solution Coil
48:57 - RVIPGFMIQG Anti-parallel b-sheet in crystal structure; Short anti-parallel
b-sheet in solution
Anti-parallel b-
sheet
77:80 - ADNG 310-helix in crystal structure; Unstructured in solution ND
1IAZ/1KD6 99.2 8:15 - VIDGSALS b-strand and 310-helix in crystal; Hydrogen bonded turn
in solution
b-strand + Coil
129:138 - DQRMYEELYY a-helix in crystal structure; Short a-helix followed by unstructured
region in solution
a-helix
1WHO/1BMW 100 4:8 - VTFTV b-strand in crystal structure; Unstructured in solution ND
16:23 - HLAVLVKY b-strand in crystal structure; Isolated b-bridge mostly unstructured
in solution
b-strand
28:34 - MAEVELR b-strand in crystal structure; Small b-strand mostly unstructured
in solution
b-strand
51:55 - VWTFD b-strand in crystal structure; Unstructured, isolated b-strand,
bridge
ND
64:70 - FNFRFLT b-strand in crystal structure; Unstructured, isolated b-bridge b-strand
75:82 - KNVFDDVV b-strand in crystal structure; Unstructured, isolated b-strand,
bridge in solution
b-strand+ Coil
a + b class of proteins
Conformational Variation in Macromolecular Models
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choice of an affinity or solubilization tag. A particularly dramatic
case of a change in the fold of a protein due to a change in the
sequence-length is that of human PRP-8 D4 structure that has a
different fold from that determined for a shorter D4 construct
(Figure 3A). In the case of multi-protein complexes, co-expression
and co-purification of interacting proteins often provides a viable
Table 1. Cont.
a-class of proteins
X-ray/NMR PDB
Identity
(%) Variant Region Structural manifestation in crystal and solution structure PSIPRED analysis
2SAK/1SSN 89 38:48 - ELLSPHYVEFP b-strand in X-ray structure; Unstructured in solution Coil+ b-strand
76:81 - FRVVEL b-strand in crystal structure; Unstructured in solution b-strand
1QVE/1HPW 96.1 31:55 - AQLSEAMTLASGLKTKVSDIFSQDG Two helices connected through a turn in crystal structure;
Single helix in solution
a-helix-coil-a-helix
78:88 - VAKVTTGGTA b-strand in crystal structure; Unstructured in solution b-strand
1C44/1QND 97.6 90:95 - PQSAFF a-helix-coil-b-strand in crystal structure; Hydrogen bonded
turn in solution
a-helix-coil-b-
strand
99:102- LKIT b-strand in crystal structure; Unstructured in solution ND
105:112- MGLAMKLQ a-helix in crystal structure; Hydrogen bonded turn in solution a-helix
3IL8/1IKM 100 19:28 - PKFIKELRVI 310-helix followed by b-strand in crystal structure; b-bridge and
b-strand in solution
Coil + b-strand
66:72 - LKRAENS a-helix in crystal structure; Unstructured in solution a-helix
1TN3/1RJH 86.1 58:68 - MKCFLAFTQTK b-strand in crystal structure; Unstructured in solution b-strand + Coil
a/b class of proteins
1RRF/1U81 90.6 18:24 - MRILMVG b-strand in crystal structure; Unstructured, isolated b-strand,
bridge in solution
a-helix + b-strand
43:48 - VTTIPT b-strand in crystal structure; Unstructured, isolated b-bridge
in solution
b-strand
76:92- PLWRFQNTQGLIFVV 310-helix, unstructured followed by b-strand in crystal structure;
a-helical followed by b-strand in solution
a-helix-coil- b-
strand
99:113- RVNEAREELMRMLAE a-helix in crystal structure; Unstructured, short helix, turn
in solution
a-helix
1EZ9/1EZO 99.7 145:147- SAL b-strand in crystal structure; unstructured in solution ND
222:227- TAMTIN b-strand in crystal structure; unstructured in solution ND
258:266- FVGVLSAGI b-strand in crystal structure; unstructured in solution b-strand
305:311- KSYEEEL a-helix in crystal structure; turn and short helix in solution a-helix
5P21/1CRP 99.4 37:46 - EDSYRKQVVI 49:58 - ETCLLDILDT b-strand-turn- b-strand in crystal structure; Shortened b-strand
in solution
b-strand-coil- b-
strand
Small proteins
1PSP/1PCP 100 5:10 - ACRCSR a-helix in crystal structure; turn in solution b-strand
13:15- PKN 310-helix in crystal structure; unstructured in solution ND
55:59 - SEECV 310-helix in crystal structure; turn in solution ND
61:64 - QVSA 310-helix in crystal structure; turn in solution ND
1NTN/1W6B 97.3 50:52 - ESY Turn in crystal structure; unstructured in solution ND
62:68 - NCNPHPK Mix of turn in crystal structure; 310-helix in solution Coil
1BRF/1RWD 94.3 2:13 - KWVCKICGYIYD b-strand-turn- b-strand in crystal structure; isolated b-bridge
in solution
b-strand
43:51 - APKSEFEKL Mix of b-bridge, 310-helix and b-strand in crystal structure;
unstructured
in solution
a-helix
9PTI/1OA5 100 3:6 - DFCL 310-helix in crystal structure; unstructured in solution ND
1RDG/1E8J 100 18:24 - GDPDSGI Mix of b-bridge, 310-helix and b-bridge in crystal structure;
unstructured
in solution
Coil
30:33 - FEDL 310-helix in crystal structure; unstructured in solution ND
44:49 - ASKDAF Mix of b-bridge, 310-helix in crystal structure; unstructured
in solution
ND
ND - Not Determined.
doi:10.1371/journal.pone.0039993.t001
Conformational Variation in Macromolecular Models
PLoS ONE | www.plosone.org 5 July 2012 | Volume 7 | Issue 7 | e39993
Table 2. Structural variations in protein complexes.
S. No. PDB ID Region of structural variation
Structural manifestations
in the variant region
PSIPRED
Prediction
for variant
region
Disopred Prediction
(Residue numbers)
1 3HRY/3K33 50–73: AALDAEFASLFDTLDSTNKELVNR a-helix in complex, turns and coil in
individual protein structure
a-helix 72–73
2 3FII/1SFC 27–57: TSNRRLQQTQAQVDEVVDIMRVNVDKVLERD Largely unstructured in one complex
and a-helix in another complex
a-helix 28–36
3 1N7S/1XTG 167–204: MGNEIDTQNRQIDRIMEKADSNKTRIDEANQR
ATKMLG
a-helix in one complex and largely
unstructured in the other
a-helix 167–169, 171–173,
198, 204
4 3C98/3HD7 189–248: KQALSEIETRHSEIIKLENSIRELHDMFMDMAM
LVESQGEMIDRIEYNVEHAVDYVERAV
a-helix in one complex, unstructured
with distorted helix in another complex
a-helix 189, 248
5 2GRX/1IHR 164–182: PARAQALRIEGQVKVKFDV a-helix, b-strand in complex,
b-strand in individual protein
a-helix, b-
strand
164–168
221–235: GSGIVVNILFKINGT Coil and b-strand in complex,
b-strand in individual protein
b-strand 221, 236
6 2JKR/2BP5 316–325: LAQKIEVRIP b-strand in one complex, unstructured
in the other
b-strand 316–319
419–434: IKWVRYIGRSGIYETR b-strand in one complex, unstructured
in the other
b-strand 431–434
7 1CDJ/1G9M 54–69: RADSRRSLWDQG a-helix in complex, turn in individual
protein
a-helix 58–59, 62–64
12–18: VELTCTA b-strand in individual protein, coil
in complex
b-strand 12,18
8 3B2V/1IVO 19–32: FEDHFLSLQRMFNN a-helix in one complex and unstructured
in other
a-helix 19,32
92–97: YALAVL b-strand in one complex and no electron
density in other
a-helix –
9 1BGW/2RGR 630–682: LQGNDKDYIDLAFSKKKADDRKEWLRQYEPG
TVLDPTLKEIPISDFINKELI
a-helix in complex. Unstructured in
individual protein structure
a-helix 634
10 1K4S/1A36 633–710: QRAPPKTFEKSMMNLQTKIDAKKEQLADARR
DLKSAKADAKVMKDAKTKKVVESKKKAVQRLEEQLMKL
EVQATDREE
a-helix in one complex and unstructured
in the other
a-helix 633–636,639–
640,669–687,700–
701,703–710
11 1SER/1SRY 36–86: EVQELKKRLQEVQTERNQVAKRVPKAPPEEKE
ALIARGKALGEEAKRLEEA
Unstructured in complex and a-helix in
individual structure
A-helix 48, 50–69
12 1HLO/1R05 12–27: ADKRAHHNALERKRRD a-helix in the complex (crystal) and
unstructured in the individual protein
(NMR)
a-helix 27-Dec
13 1B70/1EIY 6–85: LAAIQNARDLEELKALKARYLGKKGLLTQEM
KGLSALPLEERRKRGQELNAIKAALEAALEAREKALEEAAL
KEALERER
a-helix in one complex and unstructured
in the other
a-helix –
14 1JYE/1EFA 5–13: TLYDVAEYA a-helix in complex, unstructured in
individual protein
a-helix 11
16–25: SYQTVSRVVN a-helix in complex, unstructured in
individual protein
a-helix and b-
strand
16–17
32–46: AKTREKVEAAMAELN a-helix in complex, unstructured in
individual protein
a-helix 32–37
15 1D1U/1D0E 67–84: SQEARLGIKPHIQRLLDQ a-helix in one complex and unstructured
in other
a-helix 69–71, 83–84
99–114: LPVKKPGTNDYRPVQD a-helix in one complex, b-strand and coil
in other
Coil 99–114
237–273: QQGTRALLQTLGNLGYRASAKKAQICQ a-helix and coil in one complex, b-strand
in the other
a-helix 238–241, 264
16 1VS5/2QOU 19–30: SIVVAIERFVKH b-strand in one complex, mostly
unstructured in other
b-strand and
a-helix
-
34–46: GKFIKRTTKLHVH b-strand in one complex, mostly
unstructured in other
b-strand 34–35, 45–46
57–67: VVEIRECRPLS b-strand in one complex, mostly
unstructured in other
b-strand –
doi:10.1371/journal.pone.0039993.t002
Conformational Variation in Macromolecular Models
PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e39993
Table 3. Conformational variation in peptide structures.
Sl. No
Peptide
PDB Peptide sequence
Structural
manifestation PSIPRED result Protein PDB Identity(%)
Structural
manifestation
1 1QWP GSNKGAIIGLM 80% a-helix 63% b- strand 3MOQ(A) 100 63% b-strand
1HZ3(A) 100 Coil
2BEG(A) 100 72% b-strand
1Z0Q(A) 100 45% a-helix
1IYT(A) 100 a-helix
2WK3(C) 100 –
2G47(C) 100 –
1AML(A) 100 45% a-helix
1BA4(A) 100 a-helix
2OTK(C) 100 72% b-strand
2 1CFG TRYLRIHPQSWVHQIALRMEVL 30% a-helix 3HNB(M) 100 80% b-strand
3HNY(M) 100 80% b-strand
3HOB(M) 100 80% b-strand
1D7P(M) 100 80% b-strand
3CDZ(B) 100 80% b-strand
2R7E(B) 100 30% b-strand
3 1P5A AVGIGALFLGFLGAAGSTMGARSX 25% a-helix 58% a-helix 2ARI(A) 100 a-helix
3ABI(A) 80 b-strand + a-helix
4 1OMQ RQIKIWFQNRRMKWKK 70% a-helix 90% b-strand 1HOM(A) 100 80% a-helix
1AHD(P) 100 a-helix
5 1DVW TLAVPGMTCAACPITVKK Coil 66% b-strand 1AFI(A) 100 22% b-strand, 27%
a-helix
1AFJ(A) 100 22% b-strand, 27%
a-helix
2HQI(A) 100 22% b-strand, 27%
a-helix
6 1IBN GLFGAIAGFIENGWEGMIDG 90% a-helix 55% a-helix 3EYM(B) 100 Coil
1MQL(B) 100 Coil
1MQN(B) 100 Coil
5HMG(B) 100 Coil
3EYK(B) 90 Coil
7 1HZ3 YEVHHQKLVFFAEDVGSNKGAIIGLM Coil 80% b-strand 2BEG(A) 100 80% b- strand
1Z0Q(A) 100 80% a-helix
1IYT(A) 100 a-helix
2WK3(C) 100 10% b-strand
3IFN(P) 100 –
1AML(A) 100 50% a-helix
1BA4(A) 100 80% a-helix
2OTK(C) 100 80% b-strand
1AMB(A) 100 90% a-helix
8 1XV7 FQWQRNIRKVRX Coil 1LFH(A) 91 a-helix
1B0L(A) 91 a-helix
9 2BP4 DAEFRHDSGYEVHHQK 70% a-helix 50% b-strand 2WK3 100 Coil
1BA6 100 Coil
1IYT 100 50% a-helix
10 2RMV GNDYEDRYYRENMARYPNQVYYRPVC Coil 50% a-helix, 15%
b-strand
3O79 96 73% a-helix
1XYW 96 73% a-helix
2KU4 96 45% a-helix
doi:10.1371/journal.pone.0039993.t003
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route towards structural characterization. Protein-protein interac-
tions often involve conformational changes that make the complex
more stable and tractable for crystallization. These conformational
changes can also be context-dependent. An example of this feature
is Synaptobrevin, a part of the vesicle-associated membrane
protein (VAMP) family that forms a component of the neuronal
SNARE (soluble N-ethylmaleimide-sensitive factor attachment
receptor) complex. The isolated solution structure of synaptobre-
vin is largely unfolded but is a well-defined helix in the SNARE
complex [16]. The structure of synaptobrevin (residues 27–57) in
complex with Neurotoxin type F from Clostridium botulinum (3FII)
[17] shows a largely disordered segment with a small b-strand at
the N terminus and a small a-helix at the C terminal end while the
same segment is a helix in the neuronal synaptic fusion complex
(PDB: 1SFC) [18]. A superposition of the two structures is shown
in Figure 3B. A search for similar stretches in the PDB yielded
several protein-complexes in which this sequence-stretch is an
ordered a-helix. For example, synaptobrevin in the complexin-
SNARE complex (PDB: 1KIL) [19] shows a well defined a-helix
similar to other SNARE complexes (PDB: 1N7S, 3HD7, 3IPD)
Figure 2. Representative examples of conformational variations. (A) All a class (B) All b class (C) a+b class (D) a/b class (E) Small proteins. A
comprehensive list of these parameters is compiled in Table 1.
doi:10.1371/journal.pone.0039993.g002
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[20]. Recombinant proteins of different sizes (based on different
expression constructs) also influence secondary structural com-
position. For example, in the case of the catalytic domains of
Protein Tyrosine Phosphatases (PTP), addition of an additional
stretch of ca 45 residues substantially influences the solubility
and propensity to crystallize. This stretch either adopts an a
helical conformation or is involved in dimerization [21].
Context-dependent conformational changes are more common
in protein-nucleic acid complexes (Figure 3C). Indeed, successful
structure determination of protein-nucleic acid complexes is
often only possible in the presence of the interacting components
(Table 2).
Peptide Structures Exemplify Conformational Selection
Structural differences in peptide structures have been exten-
sively examined in the case of the amyloid peptides and chameleon
sequences [22], [23]. For instance, the NMR structure of an eleven
residue peptide from the amyloid b A4 protein (PDB: 1QWP)
adopts a a-helical conformation. The same sequence, however,
variously adopts b-strand conformations (PDB: 3MOQ, 2BEG,
2OTK) [24], [25] a-helical segments (PDB: 1Z0Q, 1IYT, 1BA4,
1AML) [26] or coiled-coil conformations (PDB: 1HZ3) as a part of
a larger protein sequence (Figure 4A; Figure S1). Another
representative example is the NMR structure of a peptide from
the C2 domain of Factor VIII (PDB: 1CFG) [27] which is a-helical
Figure 3. Conformational variations induced by interactions with proteins and nucleic acids. Structural differences in (A) human splicing
protein Prp-8 (Full length and N-terminal deletion) variants. These structures illustrate sequence length-dependent structural changes. (B) & (C)
depict structural changes in protein-protein and protein-nucleic acid complexes.
doi:10.1371/journal.pone.0039993.g003
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in isolation. The same sequence in the context of the entire C2
domain of Factor VIII (PDB: 3HNB, 3HNY, 3HOB, 1D7P,
3CDZ, 1IQD) [28], [29], [30] adopts a b-strand conformation
(Figure 4B). It is relevant to note in this context that the secondary
structure prediction (using PSIPRED) [31] for this peptide
revealed a 22% b-strand and 63% a-helical structure.
Figure 4. Structural variability in peptide sequences. (A) Context dependent conformational changes of a peptide from the amyloid b A4
protein (PDB: 1QWP) and (B) C2 domain of Factor VIII (PDB: 1CFG).
doi:10.1371/journal.pone.0039993.g004
Figure 5. In silico methods to extract dynamic information. CONCOORD and temperature factor analysis of Prevent host death protein (Phd:
3HRY) that shows a disordered-to-ordered conformational transition upon forming a complex with the Death on curing protein (Phd-Doc complex:
3K33). The grey bar represents the region in the Phd protein that undergoes structural change upon forming the Phd-Doc complex.
doi:10.1371/journal.pone.0039993.g005
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Limitations of Temperature Factor and CONCOORD
Simulations to Examine Conformational Variation
High B-factors, classical indicators for conformational variation
or flexibility, are often ambiguous due to experimental limitations.
A case for this observation is Synaptobrevin, a protein involved in
two different complexes, one with Botulinum Neurotoxin (PDB:
3FII) and the other with SNARE complex proteins (PDB: 1SFC).
In this case, the unstructured component (PDB: 3FII) showed
slightly lower B-factor values as compared to the structured
component (PDB: 1SFC). We stress here, however, that a vast
majority of segments that show conformational variability in this
dataset can be clearly flagged by virtue of high B factors in those
stretches when compared with the rest of the protein. In these
cases, alternate conformations are also easily identifiable by in silico
methods. For example, in the Prevent-host-death (Phd) protein,
the region 50–73 forms an a-helix when involved in a complex
with the Death-on-curing (Doc) protein (PDB: 3K33) while it
remains unstructured in isolation (3HRY). The temperature
factors show a marked increase for 3HRY while in 3K33, where
the protein is structured, the region has a B-factor that is below the
average value for the protein. Consistent with this experimental
data, this stretch in 3HRY shows high RMS fluctuation in a
CONCOORD analysis that correlates well with changes in
secondary structure conformations. The Dictionary of Secondary
Structure Predictions (DSSP) output for the stretch in 3HRY
shows a largely turn-dominated profile interspersed with 310-
helices, bends and alpha helices at several points of time in the
simulation (Figure 5).
Comparison Between the Secondary Structure
Propensity and Conformational Variations
The secondary structure propensity is highlighted in several
cases of conformational differences between solution and crystal
structure. For example, in the crystal structure (PDB: 1NZN) of
the cytosolic domain of human mitochondrial fission protein Fis1,
the region E5–S13 (EAVLNELVSVED) is a-helical whereas it is
unstructured in solution (PDB: 1PC2). The PSIPRED prediction
for this stretch is a a-helix. These results from the comparative
analysis dataset of X-ray and NMR pairs are summarized in
Table 1. A comprehensive list of root-mean-square-deviations
(RMSD) for this dataset is compiled in Table S2. This aspect of
conformational selection is also seen in the case of multi-protein
complexes. In the synaptosomal associated protein complexed
with Botulinum Neurotoxin BONT/A (PDB: 1XTG), the region
M167–G204 is unstructured. In the truncated neuronal SNARE
complex (PDB: 1N7S), however, the stretch is helical, consistent
with the secondary structure prediction. A summary of these
observations, along with the output obtained from the DIS-
OPRED [32] predictions is compiled in Table 2.
Effect of Experimental Conditions on Conformational
Differences
The composition of a crystallization condition can influence the
secondary structural composition of a protein and hence facilitate
conformational selection. This analysis is compiled in Tables S3
and S4. The compilation in Table S3 suggests that polyethylene
glycols (PEG; in the molecular range of 200–4000) are involved in
the crystallization of ca 80% of the proteins in this dataset while a
minority (ca 10%) of them have salts like ammonium sulphate.
PEGs serve to aggregate protein molecules, often inducing
secondary structural features, thus increasing the chance of
crystallization [33]. This observation perhaps rationalizes the
finding that in the dataset of structural pairs (X-ray and NMR;
Table S3), most of the crystal structures showed additional
secondary structural elements than the corresponding solution
structures. While an ideal comparison would have involved a pair
of structural models (X-Ray/NMR) where the structure determi-
nation was performed under identical conditions, these are difficult
to achieve due to divergent experimental requirements of mono-
disperse solution behavior of a protein sample for NMR versus
conditions that promote systematic aggregation to form crystals.
Conformational selection, in the case of multi-protein complexes is
also facilitated by crystallization agents. For example, the
crystallization condition of the Prevent host death protein
(3HRY) where the stretch 50–73 is unstructured contains Ethylene
glycol and PEG 8000 as precipitants. Ethylene glycol is known to
decrease a-helicity and its interaction with proteins is enhanced in
the presence of high molecular weight PEG [34]. Hydrophobic
interactions are known to increase with high salt concentrations
[35]. These interactions could have facilitated the folding of the
stretch (L630–E710) in DNA Topoisomerase 2 (PDB: 2RGR) as
the salt concentrations are much higher than the corresponding
concentration in the structure without bound DNA (PDB: 1BGW).
Perhaps coincidentally, an observation on the denaturation of b
sheets at low pH [36] also correlates with the structure of the T-
cell surface glycoprotein CD4 (PDB: 1CDJ, 1G9M) which shows
well-defined b-strands when compared to its structure in complex
with two other proteins where it is unstructured. Representative
cases of conformational changes induced by crystal packing effects
are illustrated in Figure S1. It is, however, difficult to correlate
crystallization conditions or the high protein concentration in an
NMR experiment with the packing in a protein structure. This
analysis is summarized in Table S5.
The packing fraction varies in the range of 0.66 to 0.84 [37].
The average packing density of proteins is about 0.75. Compar-
ative studies of packing density and cavity analysis of similar NMR
and crystal structures for all classes of proteins was performed
using Voronoia [38]. The grid level for all the input PDBs were
adjusted to 0.2 for calculating the parameters. This analysis,
however, did not yield new information, apart from confirming
that NMR structures tend to have a slightly higher packing density
when compared to crystal structures.
Discussion
Conformational changes in proteins often provide the first step
to rationalize a functional role or to build a mechanistic hypothesis
for a biological observation. Deducing conformational variations is
thus an important step in functional annotation. This information
is also crucial for structural models that form the basis for in silico
modeling of homologous proteins or as fragments that are utilized
for de novo structural prediction. An understated feature of
currently available structural models is that they implicitly
incorporate experimental conditions, limitations inherent to the
method for structure determination and data as well as by the
length of the recombinant protein construct. These limitations, in
an extreme case, provide alternate structural models for an
identical protein sequence. This was noted, most recently, in the
case of the human PRP-8 D4 structure that has a different fold
than that determined for a shorter D4 construct (Figure 3A) [39].
In this study, we examined representative structural models in the
PDB for evidence of conformational selection or context-
dependent modeling [40], [41]. The dataset for this analysis was
spread across different structural families and multi-component
(protein-protein and protein-nucleic acid) complexes. This diverse
set of protein structures was evaluated for sequence features
(secondary structure propensity, disorder) that could suggest
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alternate conformations. In particular, aspects such as a skewed
distribution of highly fluctuating residues (G, A, S, P, D) over
weakly fluctuating residues (I, L, M, Y, F, W, H) in irregular
structural elements (loops), chameleon sequences and intrinsically
disordered proteins [42], [43] were examined. The next step
involved an examination of context dependent structural varia-
tions that could be ascribed to experimental conditions, packing,
or induction of secondary structure by binding to cognate
partners. The result of this analysis is compiled in Figure 6 and
Figure S1. This analysis suggests that methods to de-convolute
dynamic information are better served by incorporating both
sequence features (for example, disorder propensity, ambivalent
secondary structures and chameleonic sequences) and experimen-
tal conditions that nucleate or aid conformational selection.
Static structural models, such as those obtained from single
crystal X-Ray diffraction methods, incorporate dynamic informa-
tion at multiple layers. B-factors and ligand induced displacements
provide an insight into potential conformational changes and
conformational sampling. The so-called consensus structures that
involve different levels of structural overlap in multiple crystal
structures have been proposed as a route to obtain dynamic
information that is otherwise not evident from single crystal
structural models. An alternative approach involves diffuse
scattering that originates from fluctuations in the average electron
density and appears as a background on an X-ray film. This
analysis, however, requires ultra high resolution structures as the
higher order scattering makes a significant contribution at high
resolutions. Furthermore, these studies also require robust scaling
between the vibrational density of states to make a comparison
between experimental and theoretical temperature factors. The
data-set utilized in this manuscript was compiled with the aim of
having protein structural models determined using different
experimental methods. This data-set does not contain crystal
structures of the resolution required to analyze diffuse scattering.
In an effort to examine if potential conformational variants could
be deduced from a given crystal structure, we performed an
analysis using CONCOORD [44]. A significant number of
outliers, however, suggest that both normal modes and CON-
COORD analysis, the preferred route to examine structural
variations in the absence of detailed MD simulations, are
inadequate (Figure 5). Do conformational differences actually
depict characteristics similar to those of the so-called chameleon
sequences? The sequence analyses presented in Table 3 broadly
support that perspective. The sequence composition also suggests
more scope for residue fluctuations [45] supporting the view that
structural models represent conformational selection influenced by
experimental conditions.
Put together, this analysis suggests that experimental conditions
substantially influence conformational selection. The experimen-
tally determined structural model, that is the template for in silico
methods to derive dynamic information, can thus bias interpre-
tations on conformational variation and dynamics. This study
presents a case for a more comprehensive inclusion of physico-
chemical parameters associated with experimental conditions in
the interpretation of protein structural data. This analysis also
emphasizes the need to incorporate information on chameleon
sequences in protein structural models while inferring dynamic
properties of proteins.
Figure 6. Summary of the potential cause of variations in protein structural models. This data is based on information presented in
Tables 1–3. The abbreviations used here are- psipred score: differences between predicted and observed secondary structure; Disorder promoting
residues, Chameleon sequences: Classification based on aminoacid composition; Salt, pH, PEG: Effects of ionic strength, pH, high concentration of
polyethylene glycol; Packing induced, Technique/Resolution: Differences between solution and crystal structural models.
doi:10.1371/journal.pone.0039993.g006
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Methods
Dataset of Structures Used in this Analysis
A compilation of protein structures was initially based on the
SCOP (1.73 version) database. Upon the identification of
candidate structural models, an advanced search in PDB was
performed to obtain the corresponding protein structure deter-
mined either in solution by NMR or as a part of a larger
macromolecular complex. The following criteria were used to
obtain the dataset for this analysis- i. Resolution cut-off for the X-
ray crystal structures was set at 3.00 A˚ (3.9 A˚ in complexes) and ii.
Only structures with a minimum overall sequence identity of 30%
in a pair-wise alignment were selected. For this purpose, the
EMBOSS Align program was used. PyMOL was used for the
superposition of the structure pairs. The dataset of protein
structural pairs had a total of 31 pairs of structures, belonging to
five SCOP classes. The dataset for disordered proteins was
collated from DISPROT [3]. The homologues for the disordered
proteins for which PDB files were available were compiled from
the PDB. The dataset for peptide structures were obtained from
the PRF database within the DBGET integrated database retrieval
system. In this search, the peptide length was limited to 10–40
amino acids. 110 peptide structures that contained only naturally-
occurring amino acids were chosen for the study. Based on the
availability of comparable sequences within large protein struc-
tures, a dataset of 45 peptide structures were compiled.
RMSD Calculation, Temperature Factor and Normal Mode
Analysis
The root mean square deviation (RMSD) was calculated
between one X-ray crystallographic structure and the average
structure from the NMR ensemble using LSQMAN [46]. The
average of that RMSD was taken for further analysis as the
deviation between the two representative proteins. The ensemble
average for the NMR structure was calculated using MOLMOL
[47]. The B-factor analysis was also performed on all the X-ray
structures in the database presented in this work. Packing densities
and cavities of the protein molecules for each structure in the
dataset were calculated using Voronoia [38]. In this method,
packing density is defined by the equation: PD = Vvdw/(Vvdw+
Vse) where Vvdw is the assigned atomic volume inside the atoms’
Van der Waals radius and Vse is the remaining solvent excluded
volume. Only monomers of each structure were used for
calculating the packing parameters while an averaged structure
was used for calculating values in the case of solution NMR. A grid
level of 0.2 was assigned for calculating the packing densities and
cavity in each structure. Water molecules were removed from the
coordinate files and only monomer structures were considered for
calculations.
Analysis of Conformational Dynamics
Along with the crystal structures, we also used CONCOORD
(from CONstraints to COORDinates) tool [44] to predict and
analyze the likely motion(s) of the segments/motifs in proteins in
our dataset. All the simulations were performed for 1000 ps
using the default parameters to generate 1000 conformations.
The trajectory analysis of the region of differences during the
course of simulations was performed using the RMSF (root
mean square fluctuation) plots of the residues during the
simulation period. Changes in secondary structure were
analyzed using DSSP [48].
Sequence Analysis of the Regions of Conformational
Change
The peptide segments that show conformational differences
between X-Ray and NMR structures as well as protein complexes
were used as a template to search for similar sequences using
BLAST (Basic Local Alignment Search Tool) [49]. Cut-off values
for sequence identity were set at 80% with the template segment.
The secondary structure propensities of the protein sequences in
this dataset were determined using PSIPRED [31]. In case of
disordered proteins, sequence analysis were performed both using
PSIPRED and DISOPRED [32].
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